Sector Update: Health Care Stocks Flat to Lower Pre-Bell Monday

MT Newswires Live

Jul 28, 2025

Health care stocks were flat to lower pre-bell Monday, with The Health Care Select Sector SPDR Fund (XLV) down 0.1% and the iShares Biotechnology ETF (IBB) inactive.

Revvity (RVTY) shares were down more than 9% after the company reported lower fiscal Q2 adjusted earnings and cut its fiscal 2025 non-GAAP EPS guidance.

Celcuity (CELC) stock was up more than 230% after the company said a phase 3 trial of its drug gedatolisib, combined with fulvestrant, with and without palbociclib, demonstrated a "statistically significant and clinically meaningful" improvement in progression-free survival in a type of breast cancer.

BeOne Medicines (ONC) stock was up more than 2% after the company said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of Tevimbra for treating adults with resectable non-small cell lung cancer at high risk of recurrence.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2554772518"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2554772518\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2554772518?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-28 21:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2554772518","market":"hk","top_or_hot":-1,"title":"Sector Update: Health Care Stocks Flat to Lower Pre-Bell Monday","media":"MT Newswires Live","content":"<html><body><p> Health care stocks were flat to lower pre-bell Monday, with The <a href=\"https://laohu8.com/S/XLV\">Health Care Select Sector SPDR Fund</a> (XLV) down 0.1% and the <a href=\"https://laohu8.com/S/IBB\">iShares Biotechnology ETF</a> (IBB)  inactive.</p><p>Revvity (RVTY) shares were down more than 9% after the company reported lower fiscal Q2 adjusted earnings and cut its fiscal 2025 non-GAAP EPS guidance.</p><p>Celcuity (CELC) stock was up more than 230% after the company said a phase 3 trial of its drug gedatolisib, combined with fulvestrant, with and without palbociclib, demonstrated a \"statistically significant and clinically meaningful\" improvement in progression-free survival in a type of breast cancer.</p><p>BeOne <a href=\"https://laohu8.com/S/MDCO\">Medicines</a> (ONC) stock was up more than 2% after the company said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of Tevimbra for treating adults with resectable non-small cell lung cancer at high risk of recurrence.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sector Update: Health Care Stocks Flat to Lower Pre-Bell Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSector Update: Health Care Stocks Flat to Lower Pre-Bell Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-07-28 21:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Health care stocks were flat to lower pre-bell Monday, with The <a href=\"https://laohu8.com/S/XLV\">Health Care Select Sector SPDR Fund</a> (XLV) down 0.1% and the <a href=\"https://laohu8.com/S/IBB\">iShares Biotechnology ETF</a> (IBB)  inactive.</p><p>Revvity (RVTY) shares were down more than 9% after the company reported lower fiscal Q2 adjusted earnings and cut its fiscal 2025 non-GAAP EPS guidance.</p><p>Celcuity (CELC) stock was up more than 230% after the company said a phase 3 trial of its drug gedatolisib, combined with fulvestrant, with and without palbociclib, demonstrated a \"statistically significant and clinically meaningful\" improvement in progression-free survival in a type of breast cancer.</p><p>BeOne <a href=\"https://laohu8.com/S/MDCO\">Medicines</a> (ONC) stock was up more than 2% after the company said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of Tevimbra for treating adults with resectable non-small cell lung cancer at high risk of recurrence.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RVTY","symbol_name":"REVVITY INC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2554772518","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2554772518","pubTimestamp":1753708994,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Health care stocks were flat to lower pre-bell Monday, with The Health Care Select Sector SPDR Fund  down 0.1% and the iShares Biotechnology ETF   inactive.Revvity  shares were down more than 9% after the company reported lower fiscal Q2 adjusted earnings and cut its fiscal 2025 non-GAAP EPS guidance.Celcuity  stock was up more than 230% after the company said a phase 3 trial of its drug gedatolisib, combined with fulvestrant, with and without palbociclib, demonstrated a \"statistically significant and clinically meaningful\" improvement in progression-free survival in a type of breast cancer.BeOne Medicines  stock was up more than 2% after the company said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of Tevimbra for treating adults with resectable non-small cell lung cancer at high risk of recurrence.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RVTY":"REVVITY INC","ONC":"百济神州","BK4526":"热门中概股","IBB":"生物科技指数ETF-iShares Nasdaq","BK4588":"碎股","BK4585":"ETF&股票定投概念","BK4139":"生物科技","BK4581":"高盛持仓","CELC":"Celcuity Inc","BK4121":"生命科学工具和服务","XLV":"健康照护类股ETF-SPDR"},"translate_title":"行业更新：医疗保健股周一盘前持平至走低","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RVTY":0.9,"XLV":0.9,"ONC":0.9,"CELC":0.9,"IBB":0.9},"content_text":"Health care stocks were flat to lower pre-bell Monday, with The Health Care Select Sector SPDR Fund (XLV) down 0.1% and the iShares Biotechnology ETF (IBB)  inactive.Revvity (RVTY) shares were down more than 9% after the company reported lower fiscal Q2 adjusted earnings and cut its fiscal 2025 non-GAAP EPS guidance.Celcuity (CELC) stock was up more than 230% after the company said a phase 3 trial of its drug gedatolisib, combined with fulvestrant, with and without palbociclib, demonstrated a \"statistically significant and clinically meaningful\" improvement in progression-free survival in a type of breast cancer.BeOne Medicines (ONC) stock was up more than 2% after the company said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of Tevimbra for treating adults with resectable non-small cell lung cancer at high risk of recurrence.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}